Biomarker for steatohepatitis (fatty liver disease) identified

5 marzo 2015

Steatohepatitis (fatty liver disease) is a disease that is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease – right up to cirrhosis and cancer of the liver — but it is known that it comes with an increased risk of heart attack and kidney damage. Now researchers report that a biomarker for the illness has been identified.